Cardinal Health (CAH) Cash & Equivalents (2009 - 2026)

Cardinal Health has disclosed Cash & Equivalents across 18 years of filings, most recently posting $3.9 billion for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $3.9 billion, up 18.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 billion (up 18.37% YoY), and the FY2025 annual result was $3.9 billion, down 24.53% from the prior year.
• Cash & Equivalents came in at $3.9 billion for Q1 2026 at Cardinal Health, up from $2.8 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $5.1 billion in Q2 2024 to a low of $2.4 billion in Q1 2022.
• The 5-year median for Cash & Equivalents is $3.9 billion (2023), against an average of $3.8 billion.
• Across the five-year window, Cash & Equivalents plunged 32.67% in 2022 and soared 69.35% in 2023, its largest moves.
• Cardinal Health's Cash & Equivalents stood at $3.7 billion in 2022, then climbed by 25.64% to $4.6 billion in 2023, then declined by 17.01% to $3.8 billion in 2024, then retreated by 27.11% to $2.8 billion in 2025, then soared by 41.77% to $3.9 billion in 2026.
• The last three Cash & Equivalents figures came in at $3.9 billion (Q1 2026), $2.8 billion (Q4 2025), and $4.6 billion (Q3 2025), per Business Quant data.